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Abstract
Background: Human T-cell leukemia virus type 1 (HTLV-1) is the etiologic agent of adult T-cell leukemia, a
malignancy characterized by uncontrolled proliferation of virally-infected CD4+ T-cells. Hypercalcemia and bone
lesions due to osteoclast-mediated bone resorption are frequently associated with more aggressive forms of the
disease. The HTLV-1 provirus contains a unique antisense gene that expresses HTLV-1 basic leucine zipper (bZIP)
factor (HBZ). HBZ is localized to the nucleus where it regulates levels of transcription by binding to certain cellular
transcriptional regulators. Among its protein targets, HBZ forms a stable complex with the homologous cellular
coactivators, p300 and CBP, which is modulated through two N-terminal LXXLL motifs in the viral protein and the
conserved KIX domain in the coactivators.
Results: To determine the effects of these interactions on transcription, we performed a preliminary microarray
analysis, comparing levels of gene expression in cells with wild-type HBZ versus cells with HBZ mutated in its
LXXLL motifs. DKK1, which encodes the secreted Wnt signaling inhibitor, Dickkopf-1 (Dkk1), was confirmed to be
transcriptionally activated by HBZ, but not its mutant. Dkk1 plays a major role in the development of bone lesions
caused by multiple myeloma. In parallel with the initial findings, activation of Dkk1 expression by HBZ was
abrogated by siRNA-mediated knockdown of p300/CBP or by a truncated form of p300 containing the KIX domain.
Among HTLV-1-infected T-cell lines tested, the detection of Dkk1 mRNA partially correlated with a threshold level
of HBZ mRNA. In addition, an uninfected and an HTLV-1-infected T-cell line transfected with an HBZ expression
vector exhibited de novo and increased DKK1 transcription, respectively. In contrast to HBZ, The HTLV-1 Tax protein
repressed Dkk1 expression.
Conclusions: These data indicate that HBZ activates Dkk1 expression through its interaction with p300/CBP.
However, this effect is limited in HTLV-1-infected T-cell lines, which in part, may be due to suppression of Dkk1
expression by Tax. Consequently, the ability of HBZ to regulate expression of Dkk1 and possibly other cellular
genes may only be significant during late stages of ATL, when Tax expression is repressed.
Background
Human T-cell leukemia virus type 1 is the etiologic
agent of adult T-cell leukemia (ATL) [1-3]. ATL is char-
acterized by uncontrolled proliferation of virally-infected
CD4 + T-cells that are capable of invading the skin and
other organs [4]. Patients diagnosed with the most
severe forms of ATL, the acute and lymphoma subtypes,
exhibit a mean survival time of less than one year and
are ultimately unresponsive to chemotherapy [5]. These
late stages of ATL are often associated with elevated
serum calcium concentrations and sometimes with the
development of lytic bone lesions, with the former con-
dition frequently serving as the underlying cause of
patient mortality [6-9]. Bone involvement of ATL is
linked to a marked increase in the population of active
osteoclasts [7,9]. This change is believed to shift the bal-
ance between bone resorption by these cells and matrix
formation by osteoblasts in favor of overall bone loss.
ATL cells from patients and HTLV-1-infected T-cells
maintained in culture have been reported to overexpress
and secrete specific cytokines and other effectors that
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stimulate the proliferation of osteoclast precursors and/
or promote osteoclast differentiation, such as IL-1, IL-6,
TGF-b, TNF-a and PTH-rP [10-15]. In addition, ATL
cells from patients with hypercalcemia have been found
to overexpress RANKL on their membrane surface
potentially through increased paracrine signaling by
MIP-1a, which is also highly expressed by these cells
[16,17]. Normal expression of RANKL on the surface of
osteoblasts plays an essential positive role in multiple
transition stages of osteoclast differentiation [18]. Possi-
bly supporting the role of RANKL in ATL, HTLV-1-
infected T-cells were recently reported to downregulate
the expression of osteoprotegrin (OPG) in co-cultured
osteoblast precursors [19]. OPG is secreted by osteo-
blasts and serves as a decoy receptor for RANKL and
competitively inhibits RANKL-mediated osteoclastogen-
esis [20,21]. OPG may also be neutralized by cross-reac-
tive antibodies produced against the viral envelop
glycoprotein, gp46 [22].
Certain cytokines implicated in promoting hypercalce-
mia and lytic bone lesions in ATL patients are believed
to contribute to similar pathological effects associated
with another hematological malignancy, multiple mye-
loma (MM; [23]). In addition to these cytokines, accu-
mulating evidence indicates that the secreted inhibitor
of the Wnt signaling pathway, Dickkopf-1 (Dkk1), may
represent one of the central mediators of bone resorp-
tion due to MM [24]. The canonical Wnt signaling
pathway is activated by the association of secreted Wnt
proteins with certain receptors within the Frizzled (Fz)
family [25]. Once associated with an Fz receptor, the
Wnt protein forms an additional interaction with the
low-density lipoprotein receptor-related protein 5 or 6
(LPR5/6) co-receptor [25]. Formation of this complex
induces an intracellular signaling pathway that promotes
the stabilization and nuclear translocation of the tran-
scriptional regulator, b-catenin. Within the nucleus b-
catenin activates gene expression through the TCF/LEF
transcription factors [25]. In mesenchymal stem cells
and other osteoblast precursors, this pathway activates
the expression of genes involved in osteoblast differen-
tiation and activation [24]. Dkk1 inhibits this process by
binding to LRP5/6, which competitively inhibits binding
by Wnt proteins [24]. Additionally, Dkk1 bound to
LRP5/6 associates with the transmembrane protein Kre-
men 1 or Kremen 2, inducing internalization and degra-
dation of LPR5/6 [24].
With respect to ATL, there is a limited understanding
of the mechanisms responsible for inducing expression
of cytokines associated with bone loss. The viral protein
Tax has been implicated in some of these processes.
Tax activates transcription from the HTLV-1 promoter
and also deregulates expression of numerous cellular
genes [26,27]. This viral protein has been reported to
activate expression of IL-1a, IL-6 and PTH-rP [28-30],
and certain transgenic mice expressing Tax develop
hypercalcemia [31]. However, Tax is dispensable for the
overexpression of IL-1b in ATL cells freshly isolated
from patients and for PTH-rP expression in certain
model systems [10,32,33]. Furthermore, expression of
Tax is frequently abolished during late stages of ATL by
deletions in the proviral genome or reversible modifica-
tions such as DNA methylation [34,35]. Therefore,
although Tax may facilitate the development of hyper-
calcemia, it is not the singular viral factor involved in
this process.
Unlike Tax, the expression of the HTLV-1 basic leu-
cine zipper factor (HBZ) is consistently detected in ATL
cells [36]. This property is due to the unique location of
the HBZ gene on the negative strand of the provirus
[37]. Therefore, HBZ transcription is regulated by a pro-
moter within the 3′ long terminal repeat (LTR) rather
than by the 5′ LTR promoter that is responsible for
transcription of all other HTLV-1 genes [38,39]. Accu-
mulating evidence indicates that HBZ plays a role in the
development of ATL (reviewed in [40]). HBZ has been
shown to repress viral transcription as well as to deregu-
late the expression of cellular genes [36,37,41-43].
Although the viral protein mediates many of these pro-
cesses, including repression of HTLV-1 transcription,
the HBZ mRNA has also been reported to alter cellular
gene expression [36,44]. The effects of the RNA were
localized to a specific hairpin secondary structure in the
5′ portion of the molecule [36].
The repression of HTLV-1 transcription by HBZ
stems from two distinct domains in the viral protein.
The C-terminal region of HBZ contains a leucine zipper
(ZIP) domain that mediates dimerization with certain
basic leucine zipper (bZIP) transcription factors [37].
Some of these cellular factors, including CREB, CREB-2,
CREM, ATF1 and c-Jun, are involved in HTLV-1 tran-
scriptional regulation. When bound by HBZ, these fac-
tors are unable to associate with the viral promoter to
activate transcription [37,45,46]. This effect is due to the
divergent basic region of the bZIP domain in HBZ that
is not known to target a specific DNA sequence. In
addition to the bZIP domain, HBZ harbors an N-term-
inal activation domain that contains two LXXLL motifs.
These motifs mediate direct binding of HBZ to the
homologous cellular coactivators CBP and p300, which
specifically occurs through the KIX domain that is con-
served between the coactivators [47,48]. CBP and p300
play central roles in the activation of HTLV-1 as well as
cellular transcription by serving as scaffolds for other
transcriptional regulators to associate with promoters
and through their histone acetyltransferase activity [48].
In the context of HTLV-1 transcription, HBZ effectively
displaces p300/CBP from the viral promoter [47]. This
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mechanism appears to be more potent than that of the
bZIP domain in mediating repression of viral
transcription.
To identify alterations in cellular gene expression
caused by the HBZ-p300/CBP interaction, we estab-
lished HeLa cell lines stably expressing HBZ or HBZ
mutated in both LXXLL motifs. A preliminary compari-
son of the gene expression profiles between these cell
lines identified DKK1 as a gene potentially upregulated
by wild-type HBZ, but not by its mutant. We confirmed
that the levels of the Dkk1 glycoprotein were higher in
the culture medium from cells expressing wild-type
HBZ compared to medium from cells expressing the
mutant. This effect was attributed to the LXXLL motifs
in HBZ, as mutations disrupting the leucine zipper and
the RNA hairpin structure did not abrogate the activa-
tion of DKK1 transcription. Knock-down of p300/CBP
by siRNA and expression of a p300 deletion mutant dra-
matically reduced Dkk1 levels, suggesting that the coac-
tivators participate in this activation. In HTLV-1-
infected T-cell lines, little or no Dkk1 mRNA was
detected. Supplemental experiments revealed that Tax
represses Dkk1 expression, which may partially account
for the limited DKK1 expression in infected cells.
Indeed, ectopic expression of HBZ was sufficient to acti-
vate DKK1 transcription in an HTLV-1-infected, as well
as an uninfected T-cell line. Based on these observa-
tions, it is possible that HBZ activates Dkk1 at some
stage of ATL. Such an event would likely contribute to
the accelerated bone resorption associated with this
disease.
Methods
Plasmids
pMACS Kk.II and pMACS 4.1 are from Miltenyi Biotec,
pcDNA3.1(-)/Myc-His is from Invitrogen, and pSG5 and
pCMV-3Tag-8 are from Agilent Technologies. pcDNA-
HBZ-SP1-Myc, pcDNA-HBZ-MutAD, pSG-Tax, pSG-
M47 and pSG-M22 have been described [47,49,50].
pSG-K88A was constructed by PCR, amplifying Tax-
K88A from CMV-K88A [51] and inserting the fragment
into the EcoRI and BamHI sites of the pSG5 vector.
pSG-HBZ-Myc was constructed by PCR, amplifying
HBZ from pcDNA-HBZ-SP1-Myc [49] and inserting the
fragment into the EcoRI site of the pSG5 vector.
pcDNA-HBZ-MutZIP and pcDNA-HBZ-MutHP were
constructed using the QuikChange II site-directed muta-
genesis kit (Agilent Technologies) as described by the
manufacturer to produce L168A/L182A amino acid, and
C9G/T10A/C11G/A12T/G15T nucleotide substitutions,
respectively. pCMV-p3001-300-Flag and pCMV-p3001-
700-Flag were constructed by PCR, amplifying p300 frag-
ments from pCMVb-p300-HA (Addgene, plasmid
10718) and cloning the fragments into pCMV-3Tag-8 at
the BamHI site. pSG5-THU was constructed by insert-
ing fragments of the HBZ and UBE2D2 genes into the
BglII and XbaI sites, respectively, of pSG-Tax. Primers
5′-GAAGATCTCATCGCCTCCAGCCTCCCCT and 5′-
GAAGATCTGAGCAGGAGCGCCGTGAGCGCAAG,
with inserted 5′ BglII sites were used to PCR amplify the
HBZ fragment from pcDNA-HBZ-SP1-Myc [49]. Pri-
mers GCTCTAGATGCCTGAGATTGCTCGGATC-
TACA and GCTCTAGACGTGGGCTCATAGAAAGCA
GTCAA with inserted 5′ XbaI sites were used to amplify
the UBE2D2 fragment from cDNA.
Cell culture and transfection
HeLa cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% fetal bovine
serum, 2 mM L-glutamine, 100 U/ml penicillin, and
50 μg/ml streptomycin. T-cell lines were cultured in
Iscove’s modified Dulbecco medium (IMDM) supple-
mented with 10% fetal bovine serum, 2 mM L-
glutamine, and penicillin-streptomycin. IL2 (50 U/ml,
Roche) was added to the culture medium for 1185 and
SP cells. HBZ-expressing cell lines were established by
transfecting HeLa cells with pcDNA-HBZ-SP1-Myc or
MutAD [47], or pcDNA3.1 using Lipofectamine (Invi-
trogen), followed by selection with 0.5 mg/mL G418
beginning 48 h post-transfection. Clonal cell lines were
obtained by expansion of individual cell colonies. Trans-
fection of protein expression vectors into HeLa cells or
the stable cell lines was done by electroporation with
cotransfection of pMACS 4.1 and purification of trans-
fected cells using the MACSelect system (Miltenyi Bio-
tec) as described [52]. Transfection of Jurkat and MT-2
cells was done using a Gene Pulser Xcell (Bio-Rad) to
electroporate 1.3 × 107 cells in 600-750 uL RPMI/
10 mM dextrose/0.1 mM dithiothreitol and 20 ug plas-
mid DNA (3:1 stiochiometric ratio of the expression
vector of interest to pMACS Kk.II) per 0.4 cm cuvette.
Each cell suspension was subjected to a single exponen-
tial decay pulse of 250 V/950 μF. Four cuvettes (pulses)
were used per vector. Electroporated cells were cultured
48 h. Live cells were harvested by centrifugation on
Ficoll-Paque PLUS (GE Healthcare) according to the
manufacturer’s instructions. Positively transfected cells
were then purified using the MACSelect system.
Small RNA interference
The siGENOME SMART pool M-003486-04-0005 and
M-003477-02-0005 were used to knock-down p300 and
CBP respectively, while the siGENOME Non-Targeting
siRNA pool#1 D-001206-13-05 was used as a control
(Thermo Scientific). Cells were seeded to reach ~50%
confluence on the day of transfection. Cells were trans-
fected with 25 nM of siRNA using DharmaFECT 1
siRNA transfection reagent (Thermo Scientific)
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according to the manufacturer’s instructions. The med-
ium was changed 24 h after transfection, and cells were
cultured for an additional 48 h in serum-free medium
prior to collection of the media (for Dkk1 expression)
and the cells (for checking siRNA efficiency).
Reverse transcriptase PCR
RNA was extracted from cells using TRIzol Reagent (Invi-
trogen) as described by the manufacturer. cDNA was
synthesized using the iScript Kit (Bio-Rad) as described by
the manufacturer. The DKK1a-R primer was used for
cDNA synthesis with RNA from T-cell lines; random pri-
mers were used for all other RNA samples. Real-time PCR
was performed using the iQ5 Multicolor Real-Time PCR
System (Bio-Rad). Standard curves were generated from
each PCR plate for all primer pairs on the plate using a
serial dilution of an appropriate experimental sample.
Samples were amplified in triplicate on each plate in 15 uL
reactions containing 7.5 uL 2× Maxima SYBR Green/
Fluorescein qPCR Master Mix (Fermentas) and 1 uL
cDNA diluted 1:20. Data were analyzed using iQ5 Optical
System Software (Bio-Rad). PCR efficiencies ranged from
83% to 120% with correlation coefficients of 0.95 to 1.0.
Primers used were as follows: DKK1a-F, 5′-AGACCATT-
GACAACTACCAGCCGT; DKK1a-R, 5′-TCTGGAA-
TACCCATCCAAGGTGCT; DKK1b-F, 5′-ATGCGT
CACGCTATGTGCT; DKK1b-R, 5′-TTTCCTCAATT
TCTCCTCGG; UBE2D2-F, 5′-TGCCTGAGATTGCTCG-
GATCTACA; UBE2D2-R, 5′-ACTTCTGAGTC-
CATTCCCGAGCTA; Tax-F, 5′-ATGGCCCACTTC
CCAGGGTTTGGA; Tax-R, 5′-ACCAGTCGCCTTGTA-
CACAGTCTC; HBZ-S1-F, 5′- TTAAACTTACCTA-
GACGGCGGACG; HBZ-S1-R, 5′-GCATGACACAGG
CAAGCATCGAAA; ACTB-F, 5′-ACCAACTGGGACGA-
CATGGAGAAA; ACTBR, 5′-TAGCACAGCCTGGA-
TAGCAACGTA. The DKK1b primer pair was used for
standard PCR amplification of cDNA prepared with the
DKK1a-R primer. Forty and twenty nine amplification
cycles for primer pairs DKK1b and UBE2D2, respectively,
were used to achieve product amounts close to a linear
range of amplification according to real-time PCR analysis.
Relative mRNA levels of DKK1 and ACTB among experi-
mental samples were determined using the 2-ΔΔCT method
[53], using UBE2D2 as the reference housekeeping gene.
Relative copy numbers for UBE2D2, HBZ and Tax mRNA
among HTLV-1-infected cell lines were determined by
amplification of all samples with all three primer sets and
a serial dilution of pSG-THU on the same plate and subse-
quent calculation of the mRNA copy number according to
the pSG-THU standard curve.
Detection of proteins from cellular lysates
Cellular lysates were prepared as described [54].
Amounts of total protein from lysates indicated in the
figure legends were resolved by SDS-PAGE and analyzed
by Western blot as described [54]. Primary antibodies
used for protein detection were as follows: mouse anti-
Myc (05-724) purchased from Millipore, mouse anti-actin
(MAB1501R) purchased from Chemicon International,
mouse anti-Flag M2 (F3165) purchased from Sigma-
Aldrich, and rabbit anti-p300 (sc-584) and anti-CBP
(sc-369) purchased from Santa Cruz Biotechnology. The
Tax monoclonal antibody (hybridoma 168B17-46-92) was
obtained from the NIH AIDS Research and Reference
Reagent Program.
Detection of Dkk1 in culture medium
Equal quantities of HeLa cells stably expressing wild-type
HBZ or HBZ-MutAD, or carrying pcDNA3.1 were cul-
tured for 24 h in serum-free medium prior to collection
of the media. For Figure 1D serum-free medium was sup-
plemented with tunicamycin (T7765, Sigma Aldrich) at a
final concentration of 0.1 ug/mL. Transfected cells were
cultured for 24 h in supplemented medium, purified
using the MACSelect system (Miltenyi Biotec) according
to the manufacturer’s instructions, and equal cell quanti-
ties from each transfection group were cultured in
serum-free medium for an additional 24 h prior to collec-
tion of the media. Cells and cellular debris were removed
from media by centrifugation. Proteins from 0.9-1.5 mL
of medium were precipitated on ice for 30 minutes in a
final concentration of 10% trichloroacetic acid. Protein
pellets were washed twice with ice-cold acetone and sub-
jected to SDS-PAGE and Western blot analysis. A rabbit
anti-Dkk1 (sc-25516) antibody was purchased from Santa
Cruz Biotechnology. ELISAs were performed using the
hDkk-1 DuoSet (R & D Systems) as described by the
manufacturer. The cleared culture media were collected
from transfected cells as described above, except trans-
fected cells were not cultured in serum-free medium.
Analysis of Dkk1 mRNA stability
Clonal cells, or cells transfected and enriched using the
MACSelect system (see transfection section), were plated
(1.6 × 106) on 6 cm plates and were cultured overnight
prior to replacing normal medium with medium contain-
ing a final concentration of 0.2 ug/mL actinomycin D
(A9415, Sigma Aldrich). Cells were harvested at post-
treatment times indicated in Figures 2A and 2D, and pro-
cessed for reverse transcriptase PCR analysis as described
above. Data analysis was done as described [55].
Chromatin immunoprecipitation (ChIP) and real-time PCR
analysis of ChIP DNA
Clonal cells, or cells transfected and enriched using the
MACSelect system (see transfection section), were used.
For each antibody, 250 μg of formaldehyde-crosslinked
chromatin was diluted to 1 mL with ChIP dilution
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buffer [56] and then divided into 10 and 990 μL for the
input and immunoprecipitation, respectively. Other than
this step, ChIP assays were performed as described [56].
Antibodies against acetyl-H3 (06-559) and RNA poly-
merase II (sc-9001) were purchased from Millipore and
Santa Cruz, respectively. Purified input and ChIP DNA
samples were suspended in 66 μL water. Real-time PCR
amplification of ChIP samples was performed using the
same system described above with 2.5 μL sample DNA
per 15 μL reaction. PCR efficiencies and correlation
coefficients ranged from 85%-110% and 0.99-1.0, respec-
tively. Primers used were as follows: DKK1-1853F, 5′-
TGGAATTTGGGATGGGAAGGACAC; DKK1-1854R,
5′-CACCACCAAGTAAAGCCAGTGACA; DKK1-991F,
5′-CATTCGGAAGCGTTGCGATGTGAT; DKK1-991R,
5′-ACTTGATTAGGCAGACGCGTGAGA; DKK1-331F,
5′-ACTTGTGTGCACAGTCAGCGAGTA; DKK1-331R,
5′-TTAATAAATGCAGGCGGCAGCAGG; DKK1 +
33F, 5′-AAATCCCATCCCGGCTTTGTTGTC; DKK1 +
33R, 5′-TCTCAGAAGGACTCAAGAGGGAGA.
Figure 1 Increased expression of Dkk1 by HBZ. (A) Expression of HBZ wt and HBZ-MutAD in the stable cell lines. Total cellular lysates (50 μg)
were subjected to Western blot analysis using antibodies directed against Myc (C-terminal epitope tag on HBZ) and b actin, as indicated. (B)
Levels of Dkk1 mRNA in cells expressing HBZ wt, HBZ-MutAD, or carrying the empty vector. Levels of Dkk1 mRNA were normalized to UBE2D2
mRNA following quantitative real-time PCR of reverse transcribed total cellular RNA. The graph shows data from three independent RNA
extractions, with Dkk1 mRNA levels shown relative to values obtained from cells containing the pcDNA3.1 empty vector (set to 1). (C) Levels of
Dkk1 protein in the culture medium from cells expressing HBZ wt, HBZ-MutAD, or carrying the empty vector. Acid-precipitated proteins from
culture media of indicated cell lines were resolved by SDS-PAGE and subjected to Western blot analysis using an antibody directed against Dkk1
(upper panel) or stained with Coomassie blue (lower panel). (D) Inhibition of Dkk1 glycosylation in cells expressing HBZ wt, HBZ-MutAD, or
carrying the empty vector. The indicated cell lines were treated with DMSO (vehicle) or tunicamycin, as denoted, and acid-precipitated proteins
from the culture media were analyzed by Western blot using an antibody directed against Dkk1.
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Protein- and modification-enrichment with each ampli-
con was quantified relative to the input as described
[57].
Results
Wild-type HBZ, but not HBZ-MutAD, increases the level of
Dkk1 expression
We previously characterized an interaction between
HBZ and the cellular coactivators p300 and CBP that
contributes to HBZ-mediated repression of HTLV-1
transcription [47]. In that study, binding of HBZ to
p300/CBP was substantially diminished by LL to AA
amino acid substitutions in two LXXLL motifs located
within the activation domain of the viral protein. Based
on this defect of the HBZ mutant, designated HBZ-
MutAD (schematically shown in Figure 3A), we were
interested in determining whether the HBZ-p300/CBP
interaction also affected expression of cellular genes. To
begin to test this premise, HeLa cells were used to
establish cell lines stably expressing wild-type HBZ
(HBZ wt) or HBZ-MutAD, or cell lines carrying the
empty pcDNA expression vector. HBZ wt and HBZ-
MutAD, as well as other HBZ mutants used in this
study are derived from the splice 1 variant of the viral
protein, which is the major HBZ isoform [36,58,59].
These proteins were expressed with C-terminal Myc epi-
tope tags to analyze their expression by Western blot
(Figure 1A).
Figure 2 HBZ activates Dkk1 expression at the level of transcription. (A) Dkk1 mRNA stability in cells expressing HBZ wt or carrying the
empty vector. Levels of Dkk1 mRNA were normalized to UBE2D2 mRNA following quantitative real-time PCR of reverse transcribed total cellular
RNA. The graph shows relative Dkk1 mRNA levels from cells harvested at the indicated times following treatment with actinomycin D. Dkk1
mRNA levels were set to 100% at time 0 hours for both cell lines. The graph shows data averaged from two independent experiments. (B) Levels
of histone H3 acetylation (acH3) at the DKK1 promoter in cells expressing HBZ wt or carrying the empty vector. ChIP assays were performed
using an antibody directed against acH3, and relative levels of acH3 at indicated sites with respect to the mRNA start site (+ 1) were normalized
to 1% of the input DNA following quantitative real-time PCR. The graph shows data averaged from three independent ChIP assays. (C) Levels of
RNA polymerase II (Pol. II) enrichment at the DKK1 promoter in cells expression HBZ wt or carrying the empty vector, with data averaged from
three independent ChIP assays. (D) Dkk1 mRNA stability in cells transiently transfected with HBZ wt or the empty vector, with data averaged
from two independent transfection experiments. (E) Levels of Pol. II enrichment at the DKK1 promoter in cells transiently transfected with HBZ
wt or the empty vector, with data averaged from two independent ChIP assays. (F) Western blot analysis of HBZ wt expression after transfection.
Polakowski et al. Retrovirology 2010, 7:61
http://www.retrovirology.com/content/7/1/61
Page 6 of 16
Comparison of these cells lines by preliminary gene
expression microarray analysis identified DKK1 as a can-
didate gene whose expression is upregulated by HBZ wt,
but unaffected by HBZ-MutAD. To corroborate a role
for HBZ in regulating Dkk1 expression, we first evalu-
ated Dkk1 mRNA levels among the cell lines using
quantitative reverse transcriptase PCR (qRT-PCR). For
this analysis, UBE2D2 was used as the housekeeping
gene. Compared to cells containing the empty expres-
sion vector, Dkk1 mRNA was elevated more than eight-
fold in HBZ wt-expressing cells, but only slightly ele-
vated in cells expressing HBZ-MutAD (Figure 1B).
Given that Dkk1 is a secreted protein, we analyzed its
levels in the culture medium from each of the three cell
lines by Western blot. In agreement with the observed
changes in mRNA levels, Dkk1 was found to be more
abundant in the medium from cells expressing HBZ wt
than in media from the other cell lines (Figure 1C, upper
panel). Comparative levels of total protein secreted from
the cells are shown by a Coomassie-stained protein gel
Figure 3 The two LXXLL motifs in the N-terminal activation domain of HBZ are required for activation of Dkk1 expression. (A) A
schematic representation of domains in HBZ and locations of mutations that were tested. AD denotes activation domain. BR1, 2 and 3 denote
basic region 1, 2 and 3, respectively. ZIP denotes leucine zipper. (B) Levels of Dkk1 mRNA in cells transfected with the indicated expression
vectors. Levels of Dkk1 mRNA were normalized to UBE2D2 mRNA following quantitative real-time PCR of reverse transcribed total cellular RNA.
The graph shows data from three or more independent transfections, with Dkk1 mRNA levels shown relative to values obtained from cells
transfected with the pcDNA3.1 empty vector (set to 1). Lower panels show a Western blot analysis of cellular lysates (40 μg) prepared from one
set of transfected cells. The membrane was probed with antibodies against Myc and b actin, as indicated.
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(Figure 1C, lower panel). Because Dkk1 is glycosylated, it
was detected as a doublet, and treatment of cells with the
glycosylation inhibitor, tunicamycin, reduced the detec-
tion of the upper band (Figure 1D).
HBZ regulates Dkk1 expression at the level of
transcription
HBZ is known to localize to the nucleus and directly
affect activities of multiple transcriptional regulators,
suggesting that it regulates Dkk1 expression at the level
of transcription. However, in reporter assays we found
that HBZ did not affect transcription from a region of
the DKK1 promoter extending from -1037 to + 163
with respect to the transcription start site (data not
show)[60]. This result was obtained using the reporter
plasmid in a transiently transfected or a chromosomally
integrated context. Similar negative results were
obtained when the DKK1 promoter region under analy-
sis was extended to -2034 (data not shown). Based on
these data, it was possible that the HBZ-mediated
increase in Dkk1 was due to stabilization of the mRNA.
To test this hypothesis, we treated HeLa cells stably
expressing HBZ wt or cells carrying the empty vector
with the transcriptional inhibitor, actinomycin D. Rela-
tive Dkk1 mRNA levels from these cells were then eval-
uated by qRT-PCR at various time-points following the
addition of the drug. The decrease in Dkk1 mRNA over
time was plotted on a semi-log graph to calculate the
mRNA half-life in each cell line (Figure 2A). We deter-
mined the half-lives to be 2.3 hours and 2.0 hours for
cells carrying the empty vector versus cells expressing
HBZ wt, respectively, suggesting that HBZ does not
induce stabilization of the mRNA.
We additionally performed chromatin immunoprecipi-
tation (ChIP) assays to test for protein marks at the
DKK1 promoter that are frequently associated with tran-
scriptional activation. We specifically evaluated relative
levels of acetylated histone H3 (acH3) and RNA poly-
merase II across the promoter. Real-time PCR analysis
of ChIP samples revealed that levels of acH3 and the
polymerase were significantly higher at all of the promo-
ter regions tested in cells expressing HBZ wt compared
to cells with the empty vector (Figures 2B and 2C). The
highest levels of enrichment for both protein marks
were obtained in proximity to the transcription start site
with amplicons centered at -331 and + 33 with respect
to the transcription start site. These data and the
mRNA stability data suggest that HBZ regulates Dkk1
expression at the level of transcription.
It was possible that increased Dkk1 expression in cells
stably expressing HBZ may have arisen from the genomic
integration of the expression vector or nonspecific cellu-
lar events occurring during development of the cell lines.
To test this premise, we compared Dkk1 mRNA stability
and RNA polymerase II-enrichment in HeLa cells transi-
ently transfected with either the empty or HBZ wt
expression vector (Figures 2D and 2E, respectively).
Results from these experiments paralleled those obtained
using the stable cell lines. The DKK1 mRNA half-life was
estimated at 2.4 hours for each set of transfected cells.
Figure 2F shows expression of HBZ in transiently tran-
fected cells. These data further support a role for HBZ in
activating Dkk1 expression at the level of transcription.
Activation of Dkk1 expression requires the LXXLL motifs
in the activation domain of HBZ
The N-terminal activation domain encompassing the
LXXLL motifs and the C-terminal bZIP domain in HBZ
target separate sets of transcriptional regulators. While
the activation domain interacts with p300/CBP [47], the
bZIP domain interacts with a subset of cellular bZIP
transcription factors [37,45,46,61,62]. Consequently,
these domains may differentially affect expression of a
given cellular gene. To test whether activation of DKK1
gene transcription was specifically mediated through the
LXXLL motifs, we compared Dkk1 mRNA levels in
HeLa cells transiently transfected with individual expres-
sion vectors for HBZ wt or the HBZ mutants denoted in
Figure 3A. HBZ-MutZIP contains point mutations in
the first leucine of the second and fourth heptad repeats
of the leucine zipper domain, which renders the mutant
defective for binding to c-Jun and CREB (data not
shown). HBZ-MutHP contains five 5′ nucleotide substi-
tutions that disrupt the hairpin structure of the HBZ
mRNA without altering the amino acid sequence. It was
important to evaluate this mutant due to evidence that
the RNA hairpin enhances T-cell proliferation [36].
Using qRT-PCR we found that only mutations in the
LXXLL motifs abrogated activation of DKK1 transcrip-
tion by HBZ (Figure 3B, upper panel). Expression of
HBZ wt and all mutants was detectable by Western blot
(Figure 3B, lower panel). These results suggest that acti-
vation of Dkk1 expression by HBZ involves p300/CBP.
siRNA-mediated knockdown of p300/CBP inhibits Dkk1
expression
A previous study demonstrated that p300 enhances
transcriptional activation from the DKK1 promoter
[63]. To evaluate this effect in the context of activation
of Dkk1 expression by HBZ, we used siRNA to knock-
down p300 and CBP expression in the cell lines carry-
ing the empty vector or expressing HBZ wt. Western
blot analysis revealed that cells transfected with siRNA
molecules targeting p300 and CBP contained reduced
levels of these coactivators, which was correlated with
a decrease in secreted Dkk1 (Figure 4A, compare lanes
1 and 2, and lanes 4 and 5). Although apparent in
both cell lines, this effect was more pronounced in
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cells expressing HBZ wt. No significant change in
levels of Dkk1 or the coactivators was observed from
cells transfected with siRNA containing scrambled
sequences (Figure 4, lanes 3 and 6). It is important to
note that cells remained viable over the 72 h course of
this experiment [64].
We have shown that the LXXLL motifs in HBZ spe-
cifically target the KIX domain that is conserved
between p300 and CBP [47]. Therefore, we expected
ectopic expression of a p300 fragment containing the
KIX domain to sequester HBZ from the endogenous
coactivators. Such competitive interactions would be
expected to abrogate HBZ-mediated activation of
Dkk1 expression in a similar manner as knockdown
of the coactivators. To test this hypothesis, we
transfected cells stably expressing HBZ wt with an
expression vector for an N-terminal fragment of p300
(aa 1-700) that contains the KIX domain (aa 566-652
for p300 [65]; pCMV-p3001-700-Flag). We separately
transfected these cells with a shorter fragment of
p300 (aa 1-300) that lacks the KIX domain. These
constructs are schematically shown in Figure 4B.
Western blot analysis of culture media showed that
less Dkk1 was secreted from cells expressing p3001-
700 compared to cells transfected with the empty
expression vector or cells expressing p3001-300 (Figure
4B, upper panel). The p300 deletion mutants each
contained an N-terminal Flag epitope tag for Western
blot analysis of their expression (Figure 4B, middle
panel). Comparative levels of total protein secreted
from the cells are shown by a Coomassie-stained pro-
tein gel (Figure 4B, lower panel). These results corro-
borate a positive role for p300/CBP in regulating
DKK1 gene expression and suggest that the HBZ-KIX
domain interaction is important for transcriptional
activation of this gene.
Figure 4 p300/CBP function in HBZ-mediated activation of Dkk1 expression. (A) Levels of Dkk1 in culture media following siRNA-mediated
knockdown of p300/CBP. Acid-precipitated proteins from culture media (upper panel) and 25 μg of cellular lysates (lower panels) from the
indicated cell lines were subjected to Western blot analysis using antibodies directed against Dkk1, p300, CBP and b actin, as indicated. (B) Levels
of Dkk1 in culture media of cells co-expressing HBZ and p300 polypeptide fragments. A schematic representation of p300 domains and the
fragments transfected into HBZ-expressing cells. Domains are denoted according to reference [48]. Acid-precipitated proteins from culture media
(upper panel) and 20 μg of cellular lysates (middle panel) were subjected to Western blot analysis using an antibody directed against Dkk1 or
the Flag epitope on transfected p300 fragments, as indicated. Acid-precipitated proteins from culture media were also resolved by SDS-PAGE
and stained with Coomassie blue (lower panel).
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Tax opposes HBZ-mediated activation of Dkk1 expression
Dkk1 is not normally expressed in T-cells [66]. To test
for its expression in HTLV-1-infected T-cells, we per-
formed a standard RT-PCR analysis using a panel of
HTLV-1-infected T-cell lines. To detect low levels
of Dkk1 mRNA, we prepared cDNA using a Dkk1
mRNA-specific primer. Unlike HeLa cells, little to no
Dkk1 mRNA was detected in the infected cells (Figure
5A). Weak expression was observed in the HTLV-1-
infected T-cell lines 1185, SP, MT-2 and SLB-1. Weak
expression was also observed in the ATL cell line, ATL-
2. No Dkk1 mRNA was detected from the HTLV-1-
infected cell lines C10MJ and C8166, from the ATL cell
lines MT-1 and TL-OmI, or from uninfected Jurkat T-
cells. Because Dkk1 mRNA levels were below the quan-
titative range of real-time PCR, qRT-PCR was not used
for this analysis.
In addition to HBZ, the viral transcription factor Tax
functions to deregulate cellular gene expression and is
strongly expressed in most HTLV-1-infected cell lines.
Tax has specifically been shown to upregulate transcrip-
tion through b-catenin, a pathway inhibited by Dkk1
[67]. Consequently, we tested whether Tax repressed
DKK1 gene expression in HeLa cells transfected with an
expression vector for wild-type Tax or individual Tax
mutant expression vectors, including M47, M22 and
K88A. M47 is defective for Tax-mediated transcriptional
activation through CREB and SRF [68,69], M22 is
Figure 5 Tax opposes HBZ-mediated activation of Dkk1 expression. (A) Dkk1 expression in uninfected and HTLV-1-infected T-cell lines.
Levels of Dkk1 and UBE2D2 mRNA from indicated cell lines were analyzed by RT-PCR. + RT and -RT denote cDNA synthesis with and without
reverse transcriptase, respectively. (B) Levels of Dkk1 mRNA in cells transfected with the indicated expression vectors. Values were determined as
described in the legend of Figure 1B, using data from at least three independent transfections. Lower panels show a Western blot analysis of Tax
and b actin from cellular lysates (40 μg) prepared from one set of transfected cells. (C) Levels of Dkk1 in culture media from cells transfected
with pSG5 or Tax. Acid-precipitated proteins from culture media (upper panel) and 30 μg of cellular lysates (lower panels) were subjected to
western blot analysis. (D) Levels of HBZ and Tax expression in HTLV-1-infected T-cell lines. HBZ and Tax mRNA copy numbers were normalized
to the number of UBE2D2 mRNA copies following quantitative real-time PCR and construction of a standard curve for mRNA copy number
determined by amplification of 10-fold serial dilutions of the pSG-THU plasmid that contains the Tax, HBZ and UBE2D2 amplification targets. The
graph shows data from at least two independent RNA extractions from each cell line. The average mRNA copy numbers for Tax and HBZ
relative to UBE2D2 are indicated below each cell line.
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defective for Tax-mediated activation of NF-KB signal-
ing [68], and K88A is deficient for binding to the KIX
domain of p300/CBP [51]. Using qRT-PCR, we found
that Tax and M47 reduced the level of Dkk1 mRNA
more than 3-fold, while M22 and K88A did not signifi-
cantly affect expression (Figure 5B). This effect paral-
leled a reduction in Dkk1 in the culture medium of cells
expressing Tax compared to that of cells transfected
with the empty vector (Figure 5C). Based on the oppos-
ing roles of HBZ and Tax on Dkk1 expression, we quan-
tified their mRNA levels in the HTLV-1-infected T-cell
lines with respect to UBE2D2 mRNA levels using qRT-
PCR. The UBE2D2 housekeeping gene exhibits stable
expression in T-cells [70]. With the exception of TL-
OmI, the expression of Tax mRNA was higher than that
of HBZ in the cell lines (Figure 5D). The average ratio
of HBZ to Tax among the cell lines tested was 0.23 ±
0.38, which is 10-fold greater than the ratio defined by
Usui et al. [71]. This variation may reflect the different
cell lines analyzed; however, the overall trend is the
same with cell lines containing substantially higher
levels of Tax mRNA compared to HBZ mRNA. TL-OmI
cells exhibited the lowest Tax mRNA signal as expected,
since these cells harbor a provirus that is transcription-
ally dormant due to methylation of the 5′ LTR [72].
TL-OmI also exhibited a similar low level of HBZ
mRNA consistent with a previous report in which
quantitative PCR was used to measure HBZ mRNA
levels [73]. The highest levels of HBZ mRNA were
found in ATL-2, 1185, SP, MT-2, C10MJ and SLB-1
cells. With the exception of C10MJ, these cell lines
exhibited detectable Dkk1 mRNA. MT-2 cells exhib-
ited the highest level of Tax expression. However,
most Tax in MT-2 cells corresponds to a fusion pro-
tein containing a portion of Env, and only a small
amount of 40 kDa Tax is present in these cells [74].
These results suggest that a threshold concentration of
HBZ is required for transcriptional activation of Dkk1.
It is also possible that Tax limits effects of HBZ on
DKK1 gene expression.
To determine whether Tax abrogates the activation
of Dkk1 expression by HBZ, we transiently trans-
fected HeLa cells with HBZ and Tax expression vec-
tors alone, or in combination, and measured levels of
Dkk1 protein and mRNA (Figure 6). Levels of Dkk1
protein secreted by transfected cells were quantified
from culture media by ELISA. Compared to cells
transfected with the control vector, the expression of
HBZ and Tax led to an increase and a decrease of
Dkk1 in the culture medium, respectively (Figure 6A).
Strikingly, when cells were cotransfected with both
HBZ and Tax, the level of Dkk1 was comparable to
that of the cells transfected with the empty vector. A
similar pattern was observed for the relative levels of
Dkk1 mRNA from transfected cells, as determined by
qRT-PCR (Figure 6B). Figure 6C shows the expression
of HBZ and Tax in transfected cells. These results
indicate that each viral protein is able to counteract
the regulatory function of the other on Dkk1
expression.
HBZ activates DKK1 gene transcription in an uninfected
and an HTLV-1-infected T-cell line
We were interested in determining whether the expres-
sion of HBZ alone induces DKK1 gene expression in
T-cells, and whether the increased abundance of HBZ
would overcome possible Tax-mediated repression of
this gene in HTLV-1-infected cells. To test these possi-
bilities, we transfected Jurkat and MT-2 cells with an
expression vector for HBZ and analyzed Dkk1 mRNA
levels using standard RT-PCR. MT-2 cells were selected
from the panel of HTLV-1-infected cells lines because
they were more amenable to our method of transfection
than the other cell lines. Following transfection of HBZ,
we observed a significant increase in Dkk1 mRNA in
MT-2 cells and de novo detection of Dkk1 mRNA in
Jurkat cells (Figure 7A). However, Dkk1 was not
detected in culture media by Western blot (data not
shown). Western blot analysis confirmed HBZ expres-
sion (Figure 7B). Because Jurkat cells are uninfected, the
HBZ-mediated increase in Dkk1 mRNA does not corre-
spond to repression of HTLV-1 transcription, and there-
fore, the repression of Tax expression. These results
indicate that HBZ is capable of inducing DKK1 gene
transcription in T-cells and overcoming the repressive
effect of Tax.
Discussion
In the current study, we showed that HBZ activates the
expression of the secreted Wnt signaling pathway inhibi-
tor, Dkk1. The significance of this finding lies with the
fact that elevated Dkk1 expression is implicated in the
development of lytic bone lesions due to MM [75,76],
and this pathological effect occurs more frequently in
patients with advanced stages of ATL [23]. Bone lesions
due to both malignancies are caused by an increase in
the number of osteoclasts encompassing these lesions
[23]. This alteration of the bone microenvironment dis-
rupts the balance between matrix synthesis by mature
osteoblasts and bone resorption by osteoclasts, favoring
bone resorption. Because Wnt signaling is essential for
the differentiation of mesenchymal stem cells into
mature osteoblasts [24], Dkk1 effectively reduces the
population of these cells, thereby diminishing matrix
synthesis. Concomitantly, Dkk1 may favor an increase in
the number of osteoblast precursors by stimulating pro-
liferation of mesenchymal stem cells [77]. Immature
osteoblasts within this population express high levels of
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Figure 6 Tax abrogates activation of Dkk1 expression by HBZ. (A) Levels of Dkk1 in culture media from cells transfected with the indicated
vectors. Dkk1 levels from culture media were detected by ELISA and normalized to the level of Dkk1 from the medium of cells transfected with
the empty vector. The graph shows data from three independent transfection assays, with Dkk1 protein levels shown relative to values obtained
from cells containing the pSG5 empty vector. A 1:1 stoichiometric ratio was used for cotransfection of HBZ and Tax expression vectors. (B) Levels
of Dkk1 mRNA from cells transfected with the indicated vectors. Levels of Dkk1 mRNA were normalized to UBE2D2 mRNA following quantitative
real-time PCR of reverse transcribed total cellular RNA. The graph shows data from two independent experiments, with Dkk1 mRNA levels shown
relative to values obtained from cells containing the pSG5 empty vector (set to 1). (C) Expression of HBZ and Tax after transfection. Total cellular
lysates (25 μg) were subjected to Western blot analysis using antibodies directed against Tax, Myc (C-terminal epitope tag on HBZ) and b actin,
as indicated.
Figure 7 HBZ activates Dkk1 expression in an uninfected and an HTLV-1-infected T-cell line. (A) Dkk1 expression in uninfected and HTLV-
1-infected T-cell lines. Levels of Dkk1 and UBE2D2 mRNA were analyzed by reverse transcriptase PCR. Cell lines and expression vectors are
indicated. + RT and -RT denote cDNA synthesis with and without (mock synthesis) reverse transcriptase, respectively. (B) Ectopic expression of
HBZ in transfected cells. Total cellular lysates from Jurkat (35 μg) and MT-2 (125 μg) cells were subjected to Western blot analysis using
antibodies directed against Myc and b actin, as indicated.
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RANKL [78], which plays a central role in osteoclasto-
genesis [18]. In addition to these effects, Dkk1 was
recently shown to counteract Wnt3a-mediated negative
and positive regulation of RANKL and OPG expression,
respectively, in osteoblasts [79]. Specifically, Dkk1
increases membrane-bound RANKL on these cells and
decreases extracellular concentrations of the OPG decoy
receptor. Such a shift in the ratio of RANKL to OPG
plays a major role in bone resorption associated with
MM [80]. Elevated RANKL expression and reduced
OPG expression have been reported to promote the
osteoclastogenesis associated with ATL. Indeed, Nosaka
et al. (2002) showed that elevated RANKL expression in
ATL cells directly correlated with hypercalcemia [16].
Recently, HTLV-1-infected cells were found to deregu-
late the expression of OPG in osteoblast precursors [19].
Based on these findings, it is possible that, in some cir-
cumstances, HBZ activates Dkk1 expression, thereby
indirectly facilitating changes in RANKL and OPG
expression.
An HBZ-mediated increase in the level of Dkk1 may
represent one of multiple possible mechanisms or con-
tributing factors that culminate in the bone resorption
associated with ATL. A number of the cytokines have
been implicated in this process, but most are not consis-
tently overexpressed in, or do not have their expression
restricted to, ATL cells from patients specifically pre-
senting with hypercalcemia and/or bone lesions [81].
However, elevated RANKL expression in ATL cells does
correlate well with these pathological effects. Although
autocrine signaling through MIP-1a has been reported
to underlie increased RANKL expression in ATL cells
[17], it is possible that secretion of Dkk1 may stimulate
RANKL expression in other cell types within the bone
microenvironment. The status of Dkk1 levels in ATL
patients, particularly from bone aspirates, has not been
reported.
As with many extracellular proteins with potential
roles in bone resorption associated with ATL, Dkk1 is
expected to elicit effects from cells located within the
bone microenvironment. However, malignant cells are
not consistently found in bone biopsies of ATL patients
presenting with hypercalcemia and/or lytic bone lesions
(for example see [7,9]). A possible explanation for this
discrepancy may involve HTLV-1 infection of cell types
other than activated CD4 + T-cells. In one study Koya-
nagi et al. (1993) identified viral DNA in CD8 + T-cells,
monocytes and B-cells (in addition to CD4 + T-cells)
from individuals infected with HTLV-1, including ATL
patients [82]. Given that MM is a B-cell-derived malig-
nancy, it is possible that HTLV-1 infection of B-cells
and HBZ-mediated activation of Dkk1 in these cells
facilitates the bone resorption process in ATL. It is also
possible that HBZ produces more robust Dkk1
expression in these cell types compared to the low
expression observed in T-cell lines.
HBZ-mediated activation of Dkk1 expression appears
to occur through an uncommon mechanism that does
not involve the promoter region immediately upstream
of the transcription start site. HBZ failed to activate
transcription from a reporter plasmid containing the
DKK1 promoter both in the context of the transiently
transfected and the chromosomally-integrated plasmid
(data not shown). Evidence that HBZ regulates Dkk1
expression at the level of transcription is based on
observations that the increase in Dkk1 mRNA by HBZ
is not due to stabilization of the mRNA. Furthermore,
HBZ expression coincides with increased acetylation of
histone H3 over the promoter and increased RNA poly-
merase II abundance in proximity to the transcription
start site, which frequently mark sites of transcriptional
activation. Although cis elements required for HBZ-
mediated activation may lie in proximity to, but outside
the DKK1 promoter regions tested, it is also possible
that HBZ functions through a distal enhancer element.
Experimental evidence indicates that optimal expression
of Dkk1 in mice relies on a currently uncharacterized
enhancer element within a 60 kb stretch of DNA that is
located 150 kb from the 3′ UTR of the DKK1 gene [83].
Such a regulatory mechanism may help dictate levels of
Dkk1 expression in human cells.
Results from this study indicate that HBZ activates
DKK1 transcription through its interactions with the
cellular coactivators, p300 and CBP. HBZ forms a stable
complex with p300/CBP through binding of two LXXLL
motifs in the activation domain of the viral protein to
the KIX domain of the coactivators [47]. Mutating both
LXXLL motifs, which severely diminishes binding to
p300/CBP, rendered the viral protein incapable of acti-
vating DKK1 transcription. In contrast, no loss in tran-
scriptional activation was observed using an HBZ
mutant with a defect in binding certain cellular bZIP
transcription factors. Furthermore, an N-terminal frag-
ment of p300 containing the KIX domain abrogated
HBZ-mediated activation of Dkk1 expression, indicative
of a competitive effect by this coactivator fragment. This
observation paralleled results involving siRNA-mediated
knockdown of p300 and CBP.
It is currently unclear how HBZ, in conjunction with
p300/CBP, modulates Dkk1 expression. Interestingly,
recent evidence supports a role for p300 in the regula-
tion of gene expression through enhancers [84]. If an
enhancer is involved in regulating transcription from the
DKK1 promoter in human as it is in mouse, HBZ and
p300/CBP may be acting through such a genomic site.
To date, we have not detected consistent HBZ-mediated
enrichment of p300/CBP at the DKK1 promoter (data
not shown). However, it is possible that p300, acting
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through an enhancer, is not intimately associated with
the DKK1 promoter, which may limit quantification of
its enrichment at the promoter. We are currently
improving the ChIP assay to better detect proteins out-
side the immediate proximity of the DNA. Studies are
also underway to test whether HBZ and p300/CBP func-
tion through an enhancer to activate Dkk1 expression.
The ability of HBZ to activate Dkk1 expression may
be dependent upon the abundance of HBZ as well as on
other factors regulating this gene. Indeed, with the
exception of C10MJ, detection of Dkk1 mRNA appeared
to require a threshold level of HBZ mRNA among the
HTLV-1-infected T-cell lines that we tested. Further-
more, in one of these cell lines, additional production of
HBZ from a transfected vector increased the level of
Dkk1 mRNA. However, the overall level of Dkk1 expres-
sion remained relatively low in this cell line, suggesting
that potent mechanisms are in place to offset HBZ-
mediated activation. We found that one such mechan-
ism involves Tax, as this viral protein repressed Dkk1
expression. Interestingly, Tax-expressing HTLV-1 cells
have been reported to exhibit increased stability and
nuclear localization of b-catenin [67]. Although attribu-
ted to signaling through Akt, this effect may also involve
repression of Dkk1 expression.
Two Tax mutants that we tested were unable to
repress Dkk1 expression: M22, which is defective for
activation of NF-KB signaling [68], and K88A, which is
defective for binding to the KIX domain of p300/CBP
[51]. With respect to the latter mutant, it is possible
that binding of Tax and HBZ to p300/CBP produce
direct opposing effects on Dkk1 expression. Conse-
quently, the ability of HBZ to regulate expression of
Dkk1 and potentially other genes may only be signifi-
cant following loss of Tax expression, which is an
event frequently observed during progression of ATL
[35].
Acknowledgements
We would like to thank Dr. W. Sellers for the p300 plasmid (through
Addgene), Dr. P. Pekala for technical advice regarding mRNA stability
experiments, Dr. M. Matsuoka for the ATL-2, MT-1 and TL-OmI cell lines, and
Dr. C. Nicot for the C10MJ, 1185 and SP cell lines. This work was supported
by a grant from the NIH (R01CA128800) and a Research Development Grant
Program Award from East Carolina University, both to IL.
Author details
1East Carolina University, Department of Microbiology and Immunology,
Brody School of Medicine, Greenville, NC, 27834, USA. 2Université Montpellier
1, Centre d’Études d’Agents Pathogènes et Biotechnologies pour la Santé
(CPBS), CNRS/UM1/UM2 UMR 5236, Montpellier, France.
Authors’ contributions
NP and IL conceived the study. NP, HG and IL performed experiments. NP
and IL analyzed the data. NP wrote the paper. JMM provided key reagents
and important input in the design of experiments. JMM and IL critically
reviewed the manuscript. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 5 May 2010 Accepted: 23 July 2010 Published: 23 July 2010
References
1. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI,
Shirakawa S, Miyoshi I: Adult T-cell leukemia: antigen in an ATL cell line
and detection of antibodies to the antigen in human sera. Proc Natl
Acad Sci USA 1981, 78:6476-6480.
2. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC: Detection
and isolation of type C retrovirus particle from fresh and cultured
lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl
Acad Sci USA 1980, 77:7415-7419.
3. Yoshida M, Miyoshi I, Hinuma Y: Isolation and characterization of
retrovirus from cell lines of human adult T-cell leukemia and its
implication in the disease. Proc Natl Acad Sci USA 1982, 79:2031-2035.
4. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H: Adult T-cell
leukemia: clinical and hematologic features of 16 cases. Blood 1977,
50:481-492.
5. Taylor GP, Matsuoka M: Natural history of adult T-cell leukemia/
lymphoma and approaches to therapy. Oncogene 2005, 24:6047-6057.
6. Catovsky D, Greaves MF, Rose M, Galton DA, Goolden AW, McCluskey DR,
White JM, Lampert I, Bourikas G, Ireland R, Brownell AI, Bridges JM,
Blattner WA, Gallo RC: Adult T-cell lymphoma-leukaemia in Blacks from
the West Indies. Lancet 1982, 1:639-643.
7. Blayney D, Blattner W, Robert-Guroff M, Jaffe E, Fisher R, Bunn P, Patton M,
Rarick H, Gallo RC: The human T-cell leukemia/lymphoma virus in the
southeastern United States. J Am Med Assoc 1983, 250:1048-1952.
8. Bunn PA Jr, Schechter GP, Jaffe E, Blayney D, Young RC, Matthews MJ,
Blattner W, Broder S, Robert-Guroff M, Gallo RC: Clinical course of
retrovirus-associated adult T-cell lymphoma in the United States. N Engl
J Med 1983, 309:257-264.
9. Kiyokawa T, Yamaguchi K, Takeya M, Takahashi K, Watanabe T,
Matsumoto T, Lee SY, Takatsuki K: Hypercalcemia and osteoclast
proliferation in adult T-cell leukemia. Cancer 1987, 59:1187-1191.
10. Wano Y, Hattori T, Matsuoka M, Takatsuki K, Chua AO, Gubler U, Greene WC:
Interleukin 1 gene expression in adult T cell leukemia. J Clin Invest 1987,
80:911-916.
11. Niitsu Y, Urushizaki Y, Koshida Y, Terui K, Mahara K, Kohgo Y, Urushizaki I:
Expression of TGF-beta gene in adult T cell leukemia. Blood 1988,
71:263-266.
12. Kim SJ, Kehrl JH, Burton J, Tendler CL, Jeang KT, Danielpour D, Thevenin C,
Kim KY, Sporn MB, Roberts AB: Transactivation of the transforming
growth factor b1 (TGF-b1) gene by human T-lymphotropic virus type I
Tax: a potential mechanism for the increased produc-tion of TGF-b1 in
adult T-cell leukemia. J Exp Med 1990, 172:121-129.
13. Villiger PM, Cronin MT, Amenomori T, Wachsman W, Lotz M: IL-6
production by human T lymphocytes. Expression in HTLV-1-infected but
not in normal T cells. J Immunol 1991, 146:550-559.
14. Tschachler E, Robert-Guroff M, Gallo RC, Reitz MS Jr: Human T-
lymphotropic virus I-infected T cells constitutively express lymphotoxin
in vitro. Blood 1989, 73:194-201.
15. Honda S, Yamaguchi K, Miyake Y, Hayashi N, Adachi N, Kinoshita K,
Ikehara O, Kimura S, Kinoshita T, Shimotohno K, et al: Production of
parathyroid hormone-related protein in adult T-cell leukemia cells. Jpn J
Cancer Res 1988, 79:1264-1268.
16. Nosaka K, Miyamoto T, Sakai T, Mitsuya H, Suda T, Matsuoka M: Mechanism
of hypercalcemia in adult T-cell leukemia: overexpression of receptor
activator of nuclear factor kappaB ligand on adult T-cell leukemia cells.
Blood 2002, 99:634-640.
17. Okada Y, Tsukada J, Nakano K, Tonai S, Mine S, Tanaka Y: Macrophage
inflammatory protein-1alpha induces hypercalcemia in adult T-cell
leukemia. J Bone Miner Res 2004, 19:1105-1111.
18. Roodman GD: Regulation of osteoclast differentiation. Ann N Y Acad Sci
2006, 1068:100-109.
19. Shu ST, Martin CK, Thudi NK, Dirksen WP, Rosol TJ: Osteolytic bone
resorption in adult T-cell leukemia/lymphoma. Leuk Lymphoma 2010,
51:702-714.
20. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S,
Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K,
Polakowski et al. Retrovirology 2010, 7:61
http://www.retrovirology.com/content/7/1/61
Page 14 of 16
Udagawa N, Takahashi N, Suda T: Osteoclast differentiation factor is a
ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is
identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998, 95:3597-3602.
21. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R,
Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E,
Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G,
Guo J, Delaney J, Boyle WJ: Osteoprotegerin ligand is a cytokine that
regulates osteoclast differentiation and activation. Cell 1998, 93:165-176.
22. Sagara Y, Inoue Y, Sagara Y, Kashiwagi S: Involvement of molecular
mimicry between human T-cell leukemia virus type 1 gp46 and
osteoprotegerin in induction of hypercalcemia. Cancer Sci 2009,
100:490-496.
23. Roodman GD: Mechanisms of bone lesions in multiple myeloma and
lymphoma. Cancer 1997, 80:1557-1563.
24. Pinzone JJ, Hall BM, Thudi NK, Vonau M, Qiang YW, Rosol TJ,
Shaughnessy JD Jr: The role of Dickkopf-1 in bone development,
homeostasis, and disease. Blood 2009, 113:517-525.
25. Clevers H: Wnt/beta-catenin signaling in development and disease. Cell
2006, 127:469-480.
26. Polakowski N, Lemasson I: Regulation of HTLV-1 transcription by Viral and
Cellular Proteins. Recent Advances in Human Retroviruses: Principles of
Replication and Pathogenesis Advances in Retroviral Research World Scientific
2010, [Edited by A. Lever (Cambridge U U, K-T Jeang (NIH, USA) and B.
Berkhout (AMC, the Netherlands). (Series Editor).
27. Ng PW, Iha H, Iwanaga Y, Bittner M, Chen Y, Jiang Y, Gooden G, Trent JM,
Meltzer P, Jeang KT, Zeichner SL: Genome-wide expression changes
induced by HTLV-1 Tax: evidence for MLK-3 mixed lineage kinase
involvement in Tax-mediated NF-kappaB activation. Oncogene 2001,
20:4484-4496.
28. Mori N, Prager D: Transactivation of the interleukin-1alpha promoter by
human T-cell leukemia virus type I and type II Tax proteins. Blood 1996,
87:3410-3417.
29. Mori N, Shirakawa F, Shimizu H, Murakami S, Oda S, Yamamoto K, Eto S:
Transcriptional regulation of the human interleukin-6 gene promoter in
human T-cell leukemia virus type I-infected T-cell lines: evidence for the
involvement of NF-kappa B. Blood 1994, 84:2904-2911.
30. Watanabe T, Yamaguchi K, Takatsuki K, Osame M, Yoshida M: Constitutive
expression of parathyroid hormone-related protein gene in human T
cell leukemia virus type 1 (HTLV-1) carriers and adult T cell leukemia
patients that can be trans-activated by HTLV-1 tax gene. J Exp Med 1990,
172:759-765.
31. Gao L, Deng H, Zhao H, Hirbe A, Harding J, Ratner L, Weilbaecher K: HTLV-
1 Tax transgenic mice develop spontaneous osteolytic bone metastases
prevented by osteoclast inhibition. Blood 2005, 106:4294-4302.
32. Richard V, Lairmore MD, Green PL, Feuer G, Erbe RS, Albrecht B, D’Souza C,
Keller ET, Dai J, Rosol TJ: Humoral hypercalcemia of malignancy: severe
combined immunodeficient/beige mouse model of adult T-cell
lymphoma independent of human T-cell lymphotropic virus type-1 tax
expression. Am J Pathol 2001, 158:2219-2228.
33. Nadella MV, Shu ST, Dirksen WP, Thudi NK, Nadella KS, Fernandez SA,
Lairmore MD, Green PL, Rosol TJ: Expression of parathyroid hormone-
related protein during immortalization of human peripheral blood
mononuclear cells by HTLV-1: implications for transformation.
Retrovirology 2008, 5:46.
34. Tamiya S, Matsuoka M, Etoh K, Watanabe T, Kamihira S, Yamaguchi K,
Takatsuki K: Two types of defective human T-lymphotropic virus type I
provirus in adult T-cell leukemia. Blood 1996, 88:3065-3073.
35. Takeda S, Maeda M, Morikawa S, Taniguchi Y, Yasunaga J, Nosaka K,
Tanaka Y, Matsuoka M: Genetic and epigenetic inactivation of tax gene in
adult T-cell leukemia cells. Int J Cancer 2004, 109:559-567.
36. Satou Y, Yasunaga J, Yoshida M, Matsuoka M: HTLV-I basic leucine zipper
factor gene mRNA supports proliferation of adult T cell leukemia cells.
Proc Natl Acad Sci USA 2006, 103:720-725.
37. Gaudray G, Gachon F, Basbous J, Biard-Piechaczyk M, Devaux C,
Mesnard JM: The complementary strand of the human T-cell leukemia
virus type 1 RNA genome encodes a bZIP transcription factor that
down-regulates viral transcription. J Virol 2002, 76:12813-12822.
38. Yoshida M, Satou Y, Yasunaga J, Fujisawa J, Matsuoka M: Transcriptional
control of spliced and unspliced human T-cell leukemia virus type 1
bZIP factor (HBZ) gene. J Virol 2008, 82:9359-9368.
39. Landry S, Halin M, Vargas A, Lemasson I, Mesnard JM, Barbeau B:
Upregulation of human T-cell leukemia virus type 1 antisense
transcription by the viral tax protein. J Virol 2009, 83:2048-2054.
40. Matsuoka M, Green PL: The HBZ gene, a key player in HTLV-1
pathogenesis. Retrovirology 2009, 6:71.
41. Kuhlmann AS, Villaudy J, Gazzolo L, Castellazzi M, Mesnard JM, Duc
Dodon M: HTLV-1 HBZ cooperates with JunD to enhance transcription of
the human telomerase reverse transcriptase gene (hTERT). Retrovirology
2007, 4:92.
42. Zhao T, Yasunaga J, Satou Y, Nakao M, Takahashi M, Fujii M, Matsuoka M:
Human T-cell leukemia virus type 1 bZIP factor selectively suppresses
the classical pathway of NF-kappaB. Blood 2009, 113:2755-2764.
43. Arnold J, Yamamoto B, Li M, Phipps AJ, Younis I, Lairmore MD, Green PL:
Enhancement of infectivity and persistence in vivo by HBZ, a natural
antisense coded protein of HTLV-1. Blood 2006, 107:3976-3982.
44. Arnold J, Zimmerman B, Li M, Lairmore MD, Green PL: Human T-cell
leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-
lymphocyte proliferation. Blood 2008, 112:3788-3797.
45. Basbous J, Arpin C, Gaudray G, Piechaczyk M, Devaux C, Mesnard JM: The
HBZ factor of human T-cell leukemia virus type I dimerizes with
transcription factors JunB and c-Jun and modulates their transcriptional
activity. J Biol Chem 2003, 278:43620-46327.
46. Lemasson I, Lewis MR, Polakowski N, Hivin P, Cavanagh MH, Thebault S,
Barbeau B, Nyborg JK, Mesnard JM: Human T-cell leukemia virus type 1
(HTLV-1) bZIP protein interacts with the cellular transcription factor
CREB to inhibit HTLV-1 transcription. J Virol 2007, 81:1543-1553.
47. Clerc I, Polakowski N, Andre-Arpin C, Cook P, Barbeau B, Mesnard JM,
Lemasson I: An interaction between the human T cell leukemia virus
type 1 basic leucine zipper factor (HBZ) and the KIX domain of p300/
CBP contributes to the down-regulation of tax-dependent viral
transcription by HBZ. J Biol Chem 2008, 283:23903-23913.
48. Bedford DC, Kasper LH, Fukuyama T, Brindle PK: Target gene context
influences the transcriptional requirement for the KAT3 family of CBP
and p300 histone acetyltransferases. Epigenetics 2010, 5:9-15.
49. Hivin P, Basbous J, Raymond F, Henaff D, Arpin-Andre C, Robert-
Hebmann V, Barbeau B, Mesnard JM: The HBZ-SP1 isoform of human T-
cell leukemia virus type I represses JunB activity by sequestration into
nuclear bodies. Retrovirology 2007, 4:14.
50. Rousset R, Desbois C, Bantignies F, Jalinot P: Effects on NF-kappa B1/p105
processing of the interaction between the HTLV-1 transactivator Tax and
the proteasome. Nature 1996, 381:328-331.
51. Harrod R, Tang Y, Nicot C, Lu HS, Vassilev A, Nakatani Y, Giam CZ: An
exposed KID-like domain in human T-cell lymphotropic virus type 1 Tax
is responsible for the recruitment of coactivators CBP/p300. Mol Cell Biol
1998, 18:5052-5061.
52. Lemasson I, Polakowski NJ, Laybourn PJ, Nyborg JK: Tax-dependent
displacement of nucleosomes during transcriptional activation of human
T-cell leukemia virus type 1. J Biol Chem 2006, 281:13075-13082.
53. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using
real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods
2001, 25:402-408.
54. Lemasson I, Nyborg JK: Human T-cell leukemia virus type I Tax repression
of p73beta is mediated through competition for the C/H1 domain of
CBP. J Biol Chem 2001, 276:15720-15727.
55. Cherry J, Jones H, Karschner VA, Pekala PH: Post-transcriptional control of
CCAAT/enhancer-binding protein beta (C/EBPbeta) expression: formation
of a nuclear HuR-C/EBPbeta mRNA complex determines the amount of
message reaching the cytosol. J Biol Chem 2008, 283:30812-30820.
56. Lemasson I, Polakowski N, Laybourn PJ, Nyborg JK: Transcription factor
binding and histone modifications on the integrated proviral promoter
in HTLV-I-infected T-cells. J Biol Chem 2002, 277:49459-49465.
57. Frank SR, Schroeder M, Fernandez P, Taubert S, Amati B: Binding of c-Myc
to chromatin mediates mitogen-induced acetylation of histone H4 and
gene activation. Genes Dev 2001, 15:2069-2082.
58. Cavanagh M, Landry S, Audet B, Arpin-Andre C, Hivin P, Pare M-E, Thete J,
Wattel E, Marriott SJ, Barbeau B, Mesnard J-M: HTLV-I antisense transcripts
initiate in the 3’LTR and are alternatively spliced and polyadenylated.
Retrovirology 2006, 3:15.
59. Murata K, Hayashibara T, Sugahara K, Uemura A, Yamaguchi T, Harasawa H,
Hasegawa H, Tsuruda K, Okazaki T, Koji T, Miyanishi T, Yamada Y, Kamihira S:
A novel alternative splicing isoform of human T-cell leukemia virus type
Polakowski et al. Retrovirology 2010, 7:61
http://www.retrovirology.com/content/7/1/61
Page 15 of 16
1 bZIP factor (HBZ-SI) targets distinct subnuclear localization. J Virol
2006, 80:2495-2505.
60. Niida A, Hiroko T, Kasai M, Furukawa Y, Nakamura Y, Suzuki Y, Sugano S,
Akiyama T: DKK1, a negative regulator of Wnt signaling, is a target of
the beta-catenin/TCF pathway. Oncogene 2004, 23:8520-8526.
61. Thebault S, Basbous J, Hivin P, Devaux C, Mesnard JM: HBZ interacts with
JunD and stimulates its transcriptional activity. FEBS Lett 2004,
562:165-170.
62. Reinke AW, Grigoryan G, Keating AE: Identification of bZIP interaction
partners of viral proteins HBZ, MEQ, BZLF1, and K-bZIP using coiled-coil
arrays. Biochemistry 2010, 49:1985-1997.
63. Fu M, Wang C, Rao M, Wu X, Bouras T, Zhang X, Li Z, Jiao X, Yang J, Li A,
Perkins ND, Thimmapaya B, Kung AL, Munoz A, Giordano A, Lisanti MP,
Pestell RG: Cyclin D1 represses p300 transactivation through a cyclin-
dependent kinase-independent mechanism. J Biol Chem 2005,
280:29728-29742.
64. Stauffer D, Chang B, Huang J, Dunn A, Thayer M: p300/CREB-binding
protein interacts with ATR and is required for the DNA replication
checkpoint. J Biol Chem 2007, 282:9678-9687.
65. De Guzman RN, Goto NK, Dyson HJ, Wright PE: Structural basis for
cooperative transcription factor binding to the CBP coactivator. J Mol
Biol 2006, 355:1005-1013.
66. Forget MA, Turcotte S, Beauseigle D, Godin-Ethier J, Pelletier S, Martin J,
Tanguay S, Lapointe R: The Wnt pathway regulator DKK1 is preferentially
expressed in hormone-resistant breast tumours and in some common
cancer types. Br J Cancer 2007, 96:646-653.
67. Tomita M, Kikuchi A, Akiyama T, Tanaka Y, Mori N: Human T-cell leukemia
virus type 1 tax dysregulates beta-catenin signaling. J Virol 2006,
80:10497-10505.
68. Smith MR, Greene WC: Identification of HTLV-I tax trans-activator mutants
exhibiting novel transcriptional phenotypes. Genes Dev 1990, 4:1875-1885.
69. Shuh M, Derse D: Ternary complex factors and cofactors are essential for
human T-cell leukemia virus type 1 tax transactivation of the serum
response element. J Virol 2000, 74:11394-11397.
70. Hamalainen HK, Tubman JC, Vikman S, Kyrola T, Ylikoski E, Warrington JA,
Lahesmaa R: Identification and validation of endogenous reference
genes for expression profiling of T helper cell differentiation by
quantitative real-time RT-PCR. Anal Biochem 2001, 299:63-70.
71. Usui T, Yanagihara K, Tsukasaki K, Murata K, Hasegawa H, Yamada Y,
Kamihira S: Characteristic expression of HTLV-1 basic zipper factor (HBZ)
transcripts in HTLV-1 provirus-positive cells. Retrovirology 2008, 5:34.
72. Taniguchi Y, Nosaka K, Yasunaga J, Maeda M, Mueller N, Okayama A,
Matsuoka M: Silencing of human T-cell leukemia virus type I gene
transcription by epigenetic mechanisms. Retrovirology 2005, 2:64.
73. Suemori K, Fujiwara H, Ochi T, Ogawa T, Matsuoka M, Matsumoto T,
Mesnard JM, Yasukawa M: HBZ is an immunogenic protein, but not a
target antigen for human T-cell leukemia virus type 1-specific cytotoxic
T lymphocytes. J Gen Virol 2009, 90:1806-1811.
74. Miwa M, Shimotohno K, Hoshino H, Fujino M, Sugimura T: Detection of pX
proteins in human T-cell leukemia virus (HTLV)-infected cells by using
antibody against peptide deduced from sequences of X-IV DNA of
HTLV-I and Xc DNA of HTLV-II proviruses. Gann 1984, 75:752-755.
75. Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B, Shaughnessy JD Jr:
The role of the Wnt-signaling antagonist DKK1 in the development of
osteolytic lesions in multiple myeloma. N Engl J Med 2003, 349:2483-2494.
76. Qiang YW, Barlogie B, Rudikoff S, Shaughnessy JD Jr: Dkk1-induced
inhibition of Wnt signaling in osteoblast differentiation is an underlying
mechanism of bone loss in multiple myeloma. Bone 2008, 42:669-680.
77. Gregory CA, Singh H, Perry AS, Prockop DJ: The Wnt signaling inhibitor
dickkopf-1 is required for reentry into the cell cycle of human adult
stem cells from bone marrow. J Biol Chem 2003, 278:28067-28078.
78. Atkins GJ, Kostakis P, Pan B, Farrugia A, Gronthos S, Evdokiou A, Harrison K,
Findlay DM, Zannettino AC: RANKL expression is related to the
differentiation state of human osteoblasts. J Bone Miner Res 2003,
18:1088-1098.
79. Qiang YW, Chen Y, Stephens O, Brown N, Chen B, Epstein J, Barlogie B,
Shaughnessy JD Jr: Myeloma-derived Dickkopf-1 disrupts Wnt-regulated
osteoprotegerin and RANKL production by osteoblasts: a potential
mechanism underlying osteolytic bone lesions in multiple myeloma.
Blood 2008, 112:196-207.
80. Pearse RN, Sordillo EM, Yaccoby S, Wong BR, Liau DF, Colman N, Michaeli J,
Epstein J, Choi Y: Multiple myeloma disrupts the TRANCE/
osteoprotegerin cytokine axis to trigger bone destruction and promote
tumor progression. Proc Natl Acad Sci USA 2001, 98:11581-11586.
81. Matsuoka M: Human T-cell leukemia virus type I and adult T-cell
leukemia. Oncogene 2003, 22:5131-5140.
82. Koyanagi Y, Itoyama Y, Nakamura N, Takamatsu K, Kira J, Iwamasa T, Goto I,
Yamamoto N: In vivo infection of human T-cell leukemia virus type I in
non-T cells. Virology 1993, 196:25-33.
83. MacDonald BT, Adamska M, Meisler MH: Hypomorphic expression of Dkk1
in the doubleridge mouse: dose dependence and compensatory
interactions with Lrp6. Development 2004, 131:2543-2552.
84. Visel A, Blow MJ, Li Z, Zhang T, Akiyama JA, Holt A, Plajzer-Frick I,
Shoukry M, Wright C, Chen F, Afzal V, Ren B, Rubin EM, Pennacchio LA:
ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature
2009, 457:854-858.
doi:10.1186/1742-4690-7-61
Cite this article as: Polakowski et al.: Expression of a protein involved in
bone resorption, Dkk1, is activated by HTLV-1 bZIP factor through its
activation domain. Retrovirology 2010 7:61.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Polakowski et al. Retrovirology 2010, 7:61
http://www.retrovirology.com/content/7/1/61
Page 16 of 16
